Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/1996
08/28/1996EP0728128A1 Substituted phenyl compounds
08/28/1996EP0727999A1 Treatment of immunoregulatory disorders
08/28/1996EP0727998A1 Oxazoles for treating cytokine mediated diseases
08/28/1996EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
08/28/1996EP0727990A1 Compounds, compositions and treatment of allergies and inflammation
08/28/1996EP0727989A1 Butyric ester cyto-differentiating agents
08/28/1996EP0727978A1 Topical aromatic releasing compositions
08/28/1996EP0397697B1 Quinoline derivatives as antagonists of leukotriene d 4?
08/28/1996CN1129947A Polymeric matrices and their uses in pharmaceutical compositions
08/28/1996CN1129908A Therapeutic agent
08/28/1996CN1129701A New diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/28/1996CN1129581A Formulation type of medicine for relieving inflammation and pain and preparation thereof
08/28/1996CN1032648C Process for preparation of platelet activating factor antagonist
08/27/1996US5550216 Gelatinase A inhibitor, and analytical reagent thereof for the determination of gelatinase A
08/27/1996US5550164 Method for inhibiting uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
08/27/1996US5550152 Antiinflammatory agents
08/27/1996US5550143 Heterocyclic compounds
08/27/1996US5550142 Phenyl heterocycles as cox-2 inhibitors
08/27/1996US5550139 Serine protease inhibitors
08/27/1996US5550132 Treating septic shock, cachexia, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, aids
08/27/1996US5549893 Use of protein C in the treatment of purpura fulminans
08/27/1996CA2001673C Pharmaceutical composition containing piroxicam
08/27/1996CA1338561C Aromatic esters and thioesters; process for preparing the same and their use in human or animal medecine and in cosmetics
08/27/1996CA1338554C Combination of tobramycin and steroids for topical ophthalmic use
08/22/1996WO1996025497A1 New chemokines expressed in pancreas
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025403A1 α-SUBSTITUTED HYDRAZIDES HAVING CALPAIN INHIBITORY ACTIVITY
08/22/1996WO1996025397A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996WO1996025383A1 Anti-inflammatory benzoic acid derivatives
08/22/1996WO1996025171A1 Inhibition of angiogenesis using interleukin-12
08/22/1996WO1996025157A1 Il-8 receptor antagonists
08/22/1996WO1996017935A3 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
08/22/1996CA2212631A1 Anti-inflammatory benzoic acid derivatives
08/22/1996CA2212370A1 Inhibition of angiogenesis using interleukin-12
08/22/1996CA2211836A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996CA2209227A1 New chemokines expressed in pancreas
08/22/1996CA2208073A1 Alpha-substituted hydrazides having calpain inhibitory activity
08/21/1996EP0727425A1 Adhesion receptor antagonists
08/21/1996EP0726952A1 Receptor on the surface of activated t-cells:acts-4
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726897A1 Process for the preparation of n-4- (substituted phenyl)alkylthienyl]-, and n-4- (substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0726780A1 Treatment for rheumatoid arthritis
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
08/21/1996EP0726777A1 Prokaryotic expression of mhc proteins
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0614457B1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments
08/21/1996EP0540614B1 3-(1-substitutedpyrazoyl)-2-oxindole derivatives
08/21/1996EP0474672B1 New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
08/21/1996CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/21/1996CN1129441A Vitamin D analogues
08/21/1996CN1129440A Phenoxyphenyl cyclopentenyl hydroxyureas
08/21/1996CN1129397A Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
08/21/1996CN1129216A Hydroxamic acid derivatives with tricylic substitution
08/21/1996CN1129102A Catechol diether compounds as inhibitors of TNF release
08/20/1996US5547980 Antiallergens, bronchodilator
08/20/1996US5547972 1-(arlalkylaminoalkyl) imidazole derivatives
08/20/1996US5547853 CD2-binding domain of lymphocyte function associated antigen 3
08/18/1996CA2169810A1 Formulated medicines and processed foods to treat and prevent stomatitis
08/16/1996CA2169433A1 Adhesion receptor antagonists
08/15/1996WO1996024579A1 15-deoxyspergualin analogs, therapeutical use thereof, and method for preparing same
08/15/1996WO1996024384A1 Methods of inhibiting cell-cell adhesion
08/15/1996WO1996024371A1 Multifunctional enzyme
08/15/1996WO1996024350A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
08/15/1996WO1996024343A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996WO1996024339A1 Compositions comprising nanoparticles of nsaid
08/15/1996WO1996011685A3 Use of indole derivatives for the treatment of various diseases
08/15/1996WO1994020062A3 Balanoids as protein kinase c inhibitors
08/15/1996CA2212645A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996CA2212533A1 Multifunctional enzyme
08/15/1996CA2212339A1 Methods of inhibiting cell-cell adhesion
08/15/1996CA2187281A1 15-deoxyspergualin analogs, their use in therapeutics and their method of preparation
08/14/1996EP0726074A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof
08/14/1996EP0726071A2 2-Phenyl-3-azoylbenzothiopenes for inhibiting cell-cell adhesion
08/14/1996EP0725772A1 Phytosphingosine-based ceramide i analogs
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0670826A4 Fatty acid derivatives and pharmaceutical compositions containing them.
08/14/1996EP0618913B1 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
08/14/1996EP0595794B1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
08/14/1996CN1128756A Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatves as selective human NK3-receptor antagonists
08/14/1996CN1128671A Cyclosporin soft capsule composition
08/14/1996CN1032534C Method for prepn. of diaminotrifluoromethylpyridine derivatives
08/13/1996US5545669 Anti-inflammatory compounds
08/13/1996US5545641 Methods of inhibiting physiological conditions associated with an excess of bradykinin
08/13/1996US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell
08/13/1996US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody
08/13/1996US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody
08/08/1996WO1996023812A1 Proline derivatives useful as inhibitors of human leukocyte elastase
08/08/1996WO1996023791A1 Bridged indoles as matrix metalloprotease inhibitors
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023489A2 Use of carotinoids for preparing medicaments for treating dermatoses
08/08/1996CA2212236A1 Bridged indoles as matrix metalloprotease inhibitors
08/08/1996CA2210957A1 The use of carotenoids for producing drugs for the treatment of dermatoses
08/08/1996CA2209675A1 Proline derivatives useful as inhibitors of human leukocyte elastase
08/07/1996EP0724647A1 Nucleic acid ligands and improved methods for producing the same
08/07/1996EP0724599A1 Platelet-derived growth factor analogues
08/07/1996EP0724592A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors